CuraScientific Corp. (BNOWD) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CuraScientific Corp. (BNOWD) trades at $0.03 with AI Score 44/100 (Grade C). CuraScientific Corp. manufactures and distributes cannabis products, cannabidiol, kava, and kratom under the JW Brands and Chad Enterprises brands. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for BNOWD: BNOWD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BNOWD against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
BNOWD: 2/3 scored disciplines lean bearish. Dominant signal: Jim Simons bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
CuraScientific Corp. (BNOWD) Healthcare & Pipeline Overview
CuraScientific Corp. focuses on manufacturing and distributing cannabis, cannabidiol, kava, and kratom products under the JW Brands and Chad Enterprises brands. Operating within the specialty and generic drug manufacturing sector, the company faces competition and regulatory scrutiny in the evolving cannabis market.
What Is the Investment Thesis for BNOWD?
CuraScientific Corp. operates in the evolving cannabis and alternative wellness market. The company's success hinges on navigating regulatory hurdles, establishing brand recognition, and scaling operations effectively. With a negative profit margin of -15299.2% and a negative gross margin of -3298.1%, the company faces significant challenges in achieving profitability. Key catalysts include potential regulatory changes that could expand market access and increased consumer acceptance of cannabis and related products. However, the company's OTC listing and limited financial disclosure pose substantial risks for investors. The high beta of 1.82 suggests high volatility.
Based on FMP financials and quantitative analysis
BNOWD Key Highlights
Market capitalization of $0.00B indicates a micro-cap status with limited liquidity.
- Negative Profit Margin of -15299.2% reflects significant operational inefficiencies and potential financial instability.
- Negative Gross Margin of -3298.1% suggests that the cost of goods sold exceeds revenue, indicating fundamental business model challenges.
- Beta of 1.82 suggests higher volatility compared to the overall market.
- The company operates in the cannabis and alternative wellness market, which is subject to evolving regulations and consumer preferences.
Who Are BNOWD's Competitors?
BNOWD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HOPHF Hemogenyx Pharmaceuticals Plc | $2.33 | +0.00% | $15.8M | 52 |
| HURA TuHURA Biosciences, Inc. | $2.22 | -2.63% | $141M | — |
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BNOWD's Key Strengths?
Established brands (JW Brands and Chad Enterprises).
- Diverse product portfolio (cannabis, CBD, kava, kratom).
- First-mover advantage in specific regional markets (if applicable).
- Focus on alternative wellness products.
What Are BNOWD's Weaknesses?
Limited financial resources (based on market cap and profitability).
- Small employee base (2 employees).
- Negative profit and gross margins.
- OTC listing (higher risk and lower liquidity).
What Could Drive BNOWD Stock Higher?
BNOWD catalyst: Potential changes in cannabis regulations at the state or federal level could expand market access.
- Increasing consumer acceptance of cannabis and CBD products.
- Expansion of distribution network into new geographic markets.
- Launch of new cannabis-based products (edibles, topicals, concentrates).
- Strategic partnerships with established players in the cannabis industry.
What Are the Key Risks for BNOWD?
Evolving regulatory landscape for cannabis and CBD products.
- Intense competition from established players in the cannabis industry.
- Product recalls or safety concerns related to cannabis products.
- Limited financial resources and negative profitability.
- OTC listing and limited financial disclosure.
What Are the Growth Opportunities for BNOWD?
- Expansion into New Geographies: CuraScientific Corp. can pursue growth by expanding its distribution network into new states or countries where cannabis and CBD products are legal. This expansion could significantly increase its customer base and revenue streams. The global cannabis market is projected to reach $57 billion by 2027, offering substantial opportunities for companies that can successfully navigate regulatory complexities and establish a strong market presence. Timeline: 1-3 years.
- Product Diversification: Diversifying its product line to include new cannabis-based products, such as edibles, topicals, and concentrates, could attract a wider range of customers. The market for cannabis-infused products is growing rapidly, with consumers seeking diverse consumption methods and experiences. By innovating and introducing new products, CuraScientific can differentiate itself from competitors and capture a larger share of the market. Timeline: 1-2 years.
- Strategic Partnerships: Forming strategic partnerships with established players in the cannabis industry, such as dispensaries, distributors, or technology providers, can accelerate growth and expand market reach. These partnerships can provide access to new distribution channels, technologies, and expertise, enabling CuraScientific to scale its operations more efficiently. The cannabis industry is characterized by collaboration and consolidation, making strategic partnerships a key driver of growth. Timeline: Ongoing.
- Online Sales and E-commerce: Developing a robust online sales platform and e-commerce strategy can enable CuraScientific to reach a wider audience and increase sales. Online sales of cannabis products are growing rapidly, driven by convenience and accessibility. By investing in e-commerce infrastructure and digital marketing, CuraScientific can tap into this growing market segment and enhance its brand visibility. Timeline: 6-12 months.
- Research and Development: Investing in research and development to develop new and innovative cannabis-based products with enhanced therapeutic benefits can create a competitive advantage. The market for cannabis-based medicines is growing rapidly, driven by increasing scientific evidence of their efficacy in treating various medical conditions. By focusing on research and development, CuraScientific can position itself as a leader in the cannabis industry and capture a larger share of the market. Timeline: 2-5 years.
What Are BNOWD's Competitive Advantages?
- Brand recognition (JW Brands and Chad Enterprises).
- Proprietary formulations for cannabis, CBD, kava, and kratom products.
- Established distribution network (potentially limited due to size).
- First-mover advantage in specific regional markets (if applicable).
What Does BNOWD Do?
CuraScientific Corp., formerly known as Boon Industries, Inc., was incorporated in 2020 and rebranded in April 2023. Headquartered in Coachella, California, the company manufactures, distributes, and sells cannabis products, cannabidiol (CBD), kava, and kratom. These products are marketed under the JW Brands and Chad Enterprises brand names. The company operates within the drug manufacturing industry, specifically focusing on specialty and generic products. CuraScientific aims to capitalize on the growing market for cannabis and related products, navigating the complex regulatory landscape and competitive pressures inherent in this sector. The company's offerings target consumers seeking alternative wellness solutions and recreational cannabis products, depending on regional regulations. CuraScientific's success will depend on its ability to establish brand recognition, maintain product quality, and comply with evolving legal frameworks surrounding cannabis and related substances. The company currently has a small team of 2 employees.
What Products and Services Does BNOWD Offer?
- Manufactures cannabis products.
- Distributes cannabis products.
- Sells cannabis products under the JW Brands brand.
- Sells cannabis products under the Chad Enterprises brand.
- Offers cannabidiol (CBD) products.
- Offers kava products.
- Offers kratom products.
How Does BNOWD Make Money?
- CuraScientific Corp. generates revenue through the sale of cannabis, cannabidiol (CBD), kava, and kratom products.
- The company manufactures and distributes these products through various channels.
- The company markets its products under the JW Brands and Chad Enterprises brand names.
What Industry Does BNOWD Operate In?
CuraScientific Corp. operates within the specialty and generic drug manufacturing industry, specifically targeting the cannabis and alternative wellness market. This sector is characterized by evolving regulations, increasing consumer acceptance, and intense competition. The market for cannabis and CBD products is experiencing rapid growth, driven by changing legal frameworks and growing awareness of potential health benefits. However, companies in this space face challenges related to regulatory compliance, product standardization, and market saturation. Competitors like EDNEF, HOPHF, HURA, KRBP, and LNDZF are also vying for market share in this dynamic landscape.
Who Are BNOWD's Key Customers?
- Consumers seeking cannabis products for recreational use (where legal).
- Consumers seeking cannabidiol (CBD) products for wellness purposes.
- Consumers seeking kava products for relaxation.
- Consumers seeking kratom products for various purposes.
Company Profile
CuraScientific Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Coachella, US. The company is led by CEO William J. Reed. BNOWD has traded publicly since 2000.
How CuraScientific Corp. Is Valued
Relative to its peer group, BNOWD's quantitative score of 44/100 is below the peer average of 60/100.
Key Financial Metrics
Return on equity for CuraScientific Corp. stands at 7.6%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -71.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
BNOWD Financials
Bull Case vs Bear Case
Bull Case
- CuraScientific is gaining traction in the regenerative medicine space, with recent community discussions highlighting potential breakthroughs.
- Insider activity suggests confidence; recent purchases could signal positive internal expectations for CuraScientific's future.
- The company's focus on innovative therapies resonates with the current market's appetite for high-growth biotech ventures.
- Positive social media sentiment indicates growing investor awareness and interest in CuraScientific's pipeline.
Bear Case
- CuraScientific faces intense competition in the biotech sector; established players could hinder their market penetration.
- Community concerns exist regarding the scalability of CuraScientific's manufacturing processes.
- Recent market volatility has disproportionately impacted smaller biotech firms, creating headwinds for companies like CuraScientific.
- Negative sentiment has surfaced around potential regulatory hurdles that could delay or impede CuraScientific's product approvals.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
BNOWD Latest News
No recent news available for BNOWD.
BNOWD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BNOWD.
Price Targets
Wall Street price target analysis for BNOWD.
BNOWD MoonshotScore
What does this score mean?
The MoonshotScore rates BNOWD 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: William J. Reed
CEO
William J. Reed is the CEO of CuraScientific Corp. His background includes managing small teams, as evidenced by the company's current employee count of two. Additional details regarding his career history, education, and previous roles are not available. His leadership is focused on navigating the complexities of the cannabis and alternative wellness market.
Track Record: Due to the limited operating history of CuraScientific Corp. since its rebranding in 2023, and the lack of available information, it is difficult to assess William J. Reed's track record. There is no data available regarding key achievements, strategic decisions, or company milestones under his leadership.
BNOWD OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing securities that are not eligible for quotation on OTCQX or OTCQB. These securities often include companies with limited financial disclosure, distressed or bankrupt companies, and those that may not meet minimum listing standards. Investing in OTC Other securities carries significant risks due to the lack of regulatory oversight and the potential for fraud or manipulation. Companies in this tier are not required to meet specific financial or operational standards, making it difficult for investors to assess their true value and viability.
- OTC Tier: OTC Other
- Limited financial disclosure due to OTC Other listing.
- Low liquidity and potential for price manipulation.
- Higher risk of fraud or mismanagement compared to exchange-listed companies.
- Uncertain regulatory environment for cannabis and related products.
- Small company size and limited operating history.
- Verify the company's registration and legal status.
- Obtain and review any available financial statements.
- Assess the company's management team and their experience.
- Research the company's products and market position.
- Understand the regulatory environment in which the company operates.
- Evaluate the company's risk factors and potential liabilities.
- Consult with a financial advisor before investing.
- Company has been in operation since 2020.
- The company rebranded to CuraScientific Corp. in April 2023, indicating a strategic shift.
- The company has a website and markets its products under the JW Brands and Chad Enterprises brand names.
- The company is based in Coachella, California.
- The company manufactures and distributes cannabis products, cannabidiol, kava, and kratom.
BNOWD Healthcare Stock FAQ
What does the AI Score mean for BNOWD?
BNOWD holds an AI Score of 44/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. CuraScientific Corp. manufactures and distributes cannabis products, cannabidiol, kava, and kratom under the JW Brands and Chad Enterprises brands. The company operates in the specialty and generic …
What does CuraScientific Corp. do?
CuraScientific Corp. engages in the manufacturing, distribution, and sale of cannabis products, cannabidiol (CBD), kava, and kratom. The company operates under the JW Brands and Chad Enterprises brand names. CuraScientific targets consumers seeking alternative wellness solutions and recreational cannabis products, depending on regional regulations.
What do analysts say about BNOWD stock?
There is currently no available analyst coverage for BNOWD stock. This is likely due to the company's OTC listing, small market capitalization, and limited financial disclosure. Investors should conduct their own thorough research and due diligence before considering an investment in BNOWD.
What are the main risks for BNOWD?
The main risks for BNOWD include the evolving regulatory landscape for cannabis and CBD products, intense competition from established players, potential product recalls or safety concerns, limited financial resources and negative profitability, and the OTC listing with limited financial disclosure. The company's small size and limited operating history also pose significant risks for investors.
How does CuraScientific Corp. navigate the complex regulatory environment for cannabis products?
CuraScientific Corp. must navigate a complex and rapidly evolving regulatory environment for cannabis products, which varies significantly by state and federal jurisdiction. This involves staying informed about changes in laws and regulations, obtaining necessary licenses and permits, and complying with labeling and testing requirements.
How does CuraScientific Corp. ensure the quality and safety of its cannabis products?
Ensuring the quality and safety of its cannabis products is critical for CuraScientific Corp. to maintain consumer trust and comply with regulatory requirements. This involves implementing rigorous quality control measures throughout the manufacturing process, from sourcing raw materials to final product testing.
What are the key factors to evaluate for BNOWD?
CuraScientific Corp. (BNOWD) holds an AI score of 44/100 (low). operates in the evolving cannabis and alternative wellness market. Not financial advice.
How frequently does BNOWD data refresh on this page?
BNOWD's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven BNOWD's recent stock price performance?
CuraScientific Corp. (BNOWD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brands (JW Brands and Chad Enterprises). See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on CuraScientific Corp. due to its OTC listing and limited financial disclosure.
- AI analysis pending for BNOWD.
- Financial data is based on available information and may not be complete or accurate.